References
- MerchantTEKasimosJNde GraafPWMinskyBDGierkeLWGlonekT. Phospholipid profiles of human colon cancer using 31P magnetic resonance spectroscopyInt J Colorectal Dis199161216
- IkenoueTKanaiFHikibaYObataTTanakaYImamuraJ Functional analysis of PIK3CA gene mutations in human colorectal cancerCancer Res20056545627
- RoyHKOlusolaBFClemensDLKarolskiWJRatashakALynchHT AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesisCarcinogenesis2002232015
- OshimaMDinchukJEKargmanSLOshimaHHancockBKwongE Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)Cell1996878039
- HulsGKoornstraJJKleibeukerJH. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomasLancet20033622302
- NielsenCKOhdJFWikstromKMassoumiRParuchuriSJuhasM The leukotriene receptor CysLT1 and 5-lipoxygenase are upregulated in colon cancerAdv Exp Med Biol20035252014
- OhdJFNielsenCKCampbellJLandbergGLofbergHSjolanderA. Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomasGastroenterology20031245770
- YangMZhongWWSrivastavaNSlavinAYangJHoeyT G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the β-catenin pathwayProc Natl Acad Sci USA2005102602732
- YunCCSunHWangDRusoviciRCastleberryAHallRA LPA2 receptor mediates mitogenic signals in human colon cancer cellsAm J Physiol Cell Physiol2005289C211
- HannunYALinardicCM. Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipidsBiochim Biophys Acta1993115422336
- PettusBJChalfantCEHannunYA. Ceramide in apoptosis: an overview and current perspectivesBiochim Biophys Acta2002158511425
- HeinrichMWickelMWinoto-MorbachSSchneider-BrachertWWeberTBrunnerJ Ceramide as an activator lipid of cathepsin DAdv Exp Med Biol200047730515
- SpiegelSMilstienS. Sphingosine-1-phosphate: an enigmatic signalling lipidNat Rev Mol Cell Biol20034397407
- KawamoriTOstaWJohnsonKRPettusBJBielawskiJTanakaT Sphingosine kinase 1 is up-regulated in colon carcinogenesisFASEB J2006203868
- BrasitusTADudejaPKDahiyaR. Premalignant alterations in the lipid composition and fluidity of colonic brush border membranes of rats administered 1,2 dimethylhydrazineJ Clin Invest19867783140
- DillehayDLWebbSKSchmelzE-MMerrillAH. Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 miceJ Nutr199412461520
- LemonnierLADillehayDLVespremiMJAbramsJBrodyESchmelzEM. Sphingomyelin in the suppression of colon tumors: prevention versus interventionArch Biochem Biophys200341912938
- Nilssonå. The presence of sphingomyelin- and ceramide-cleaving enzymes in the small intestinal tractBiochim Biophys Acta196917633947
- DuanRDBergmanTXuNWuJChengYDuanJ Identification of human intestinal alkaline sphingomyelinase as a novel ecto-enzyme related to the nucleotide phosphodiesterase familyJ Biol Chem20032783852836
- DuanRD. Alkaline sphingomyelinase: an old enzyme with novel implicationsBiochim Biophys Acta2006176128191
- OlssonMDuanRDOhlssonLNilssonA. Rat intestinal ceramidase: purification, properties, and physiological relevanceAm J Physiol Gastrointest Liver Physiol2004287G92937
- HertervigENilssonANybergLDuanRD. Alkaline sphingomyelinase activity is decreased in human colorectal carcinomaCancer19977944853
- HertervigENilssonAChengYDuanRD. Purified intestinal alkaline sphingomyelinase inhibits proliferation without inducing apoptosis in HT-29 colon carcinoma cellsJ Cancer Res Clin Oncol200312957782
- WuJChengYNilssonADuanRD. Identification of one exon deletion of intestinal alkaline sphingomyelinase in colon cancer HT-29 cells and a differentiation-related expression of the wild-type enzyme in Caco-2 cellsCarcinogenesis200425132733
- ChengYOhlssonLDuanRD. Psyllium and fat in diets differentially affect the activities and expressions of colonic sphingomyelinases and caspase in miceBr J Nutr20049171523
- WuJNilssonAJonssonBAStenstadHAgaceWChengY Intestinal alkaline sphingomyelinase hydrolyses and inactivates platelet-activating factor by a phospholipase C activityBiochem J2006394299308
- ChengYTauschelHDNilssonåDuanRD. Administration of ursodeoxycholic acid increases the activities of alkaline sphingomyelinase and caspase-3 in rat colonScand J Gastroenterol19993491520
- LiuFChengYWuJTauschelHDDuanRD. Ursodeoxycholic acid differentially affects three types of sphingomyelinase in human colon cancer Caco 2 cellsCancer Lett20062351416
- AnderssonDNilssonADuanR. Ursolic acid and other pentacyclic triterpenoids stimulate intestinal alkaline sphingomyelinase in vitroEur J Lipid Sci Technol20061081038
- LiuJJNilssonåDuanRD. Effects of phospholipids on sphingomyelin hydrolysis induced by intestinal alkaline sphingomyelinase: an in vitro studyJ Nutr Biochem2000111927
- TepperADRuursPWiedmerTSimsPJBorstJvan BlitterswijkWJ. Sphingomyelin hydrolysis to ceramide during the execution phase of apoptosis results from phospholipid scrambling and alters cell-surface morphologyJ Cell Biol200015015564